Back
Biolase Stock Predictions
Sponsored
BIOL
Sponsored
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
BIOL
Biolase
Last Price:
0.02
Seasonality Move:
-10.06%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Biolase Stock Forecast
Will Biolase Stock Go Up Next Year?
Data Unavailable
Biolase Stock Rating
Data Unavailable
Biolase Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
biolase.com
52-Week Data
52-Week High:
1.94
52-Week Low:
0.02
Prediction Charts
Market Cap:
567.3K
Price in USD:
0.02
Volume:
280.1K
Beta:
1.60
Technical Analysis
SMA50:
0.06
SMA100:
0.09
SMA200:
0.27
52-Wk Change:
-99.15%
Stock Predictions
-
Is Biolase stock public?
Yes, Biolase is a publicly traded company. -
What is the Biolase stock quote today?
The Biolase stock price is 0.02 USD today. -
How to buy Biolase stock online?
You can buy Biolase shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-16 | 0.05 | 0.05 | 0.06 | 0.05 |
Sep-17 | 0.05 | 0.06 | 0.06 | 0.05 |
Sep-18 | 0.05 | 0.06 | 0.06 | 0.05 |
Sep-19 | 0.06 | 0.06 | 0.06 | 0.06 |
Sep-20 | 0.06 | 0.06 | 0.06 | 0.05 |
Sep-23 | 0.06 | 0.07 | 0.08 | 0.06 |
Sep-24 | 0.07 | 0.07 | 0.07 | 0.06 |
Sep-25 | 0.06 | 0.06 | 0.07 | 0.06 |
Sep-26 | 0.06 | 0.06 | 0.07 | 0.06 |
Sep-27 | 0.07 | 0.07 | 0.07 | 0.06 |
Sep-30 | 0.07 | 0.07 | 0.07 | 0.06 |
Oct-1 | 0.07 | 0.06 | 0.07 | 0.05 |
Oct-2 | 0.04 | 0.02 | 0.06 | 0.02 |
Oct-3 | 0.02 | 0.02 | 0.02 | 0.02 |
Biolase Earnings
Data Unavailable
Biolase Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.40 per share, and an increase next year of $0.24 per share.
* Biolase stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.